We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
OneMain Financial
OMF
$7.32B
| $6.12M | 0.01% |
183,729
-108,754
| -37% | -$3.86M |
|
802
MongoDB
MDB
$35.3B
| $6.1M | 0.01% |
30,995
-13,199
| -30% | -$2.35M |
|
803
Tetra Tech
TTEK
$9.06B
| $6.1M | 0.01% |
213,785
-97,865
| -31% | -$2.83M |
|
804
Hilton Worldwide
HLT
$70.8B
| $6.1M | 0.01% |
48,684
-52,354
| -52% | -$6.9M |
|
805
Banco Santander Chile
BSAC
$16.5B
| $6.09M | 0.01% |
384,784
-8,738
| -2% | -$130K |
|
806
U-Haul Holding Co
UHAL
$14.3B
| $6.09M | 0.01% |
102,139
-1,097,771
| -91% | -$63.2M |
|
807
NewMarket
NEU
$8.43B
| $6.08M | 0.01% |
19,558
-16,366
| -46% | -$5.03M |
|
|
GAP
808
The Gap Inc
GAP
$7.55B
| $6.06M | 0.01% |
540,811
+100,143
| +23% | +$1.2M |
|
809
Scansource
SCSC
$1.05B
| $6.06M | 0.01% |
207,282
+57,125
| +38% | +$1.7M |
|
810
Federated Hermes
FHI
$4.7B
| $6.05M | 0.01% |
166,732
-15,650
| -9% | -$549K |
|
811
D.R. Horton
DHI
$42.2B
| $6.05M | 0.01% |
68,044
-66,554
| -49% | -$5.33M |
|
|
QVCGA
812
DELISTED
QVC Group Inc Series A
QVCGA
| $6.04M | 0.01% |
74,133
+6,958
| +10% | +$709K |
|
813
Healthpeak Properties
DOC
$14.1B
| $6.04M | 0.01% |
240,992
-105,377
| -30% | -$2.56M |
|
814
Metallus
MTUS
$900M
| $6.03M | 0.01% |
331,960
+18,324
| +6% | +$325K |
|
815
Ambev
ABEV
$43.8B
| $6.01M | 0.01% |
2,211,304
+1,242,269
| +128% | +$3.62M |
|
|
TBI
816
Trueblue
TBI
$310M
| $6M | 0.01% |
306,422
+173,004
| +130% | +$3.51M |
|
|
CIVI
817
DELISTED
Civitas Resources
CIVI
| $5.96M | 0.01% |
102,959
+43,081
| +72% | +$2.78M |
|
818
First Citizens BancShares
FCNCA
$25.4B
| $5.95M | 0.01% |
7,913
+807
| +11% | +$650K |
|
819
Brown & Brown
BRO
$23.9B
| $5.94M | 0.01% |
104,297
-47,807
| -31% | -$2.8M |
|
|
CPE
820
DELISTED
Callon Petroleum Company
CPE
| $5.92M | 0.01% |
159,578
+42,640
| +36% | +$1.75M |
|
821
Organogenesis Holdings
ORGO
$243M
| $5.89M | 0.01% |
2,190,565
+902,291
| +70% | +$2.63M |
|
822
Protolabs
PRLB
$2.16B
| $5.86M | 0.01% |
229,634
+174,986
| +320% | +$5.2M |
|
823
Silgan Holdings
SLGN
$4.35B
| $5.85M | 0.01% |
112,873
-53,487
| -32% | -$2.62M |
|
|
COOP
824
DELISTED
Mr. Cooper
COOP
| $5.83M | 0.01% |
145,241
+65,599
| +82% | +$2.77M |
|
825
Skywest
SKYW
$4.19B
| $5.83M | 0.01% |
352,864
+141,788
| +67% | +$2.48M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.